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ARTICLE IN PRESS

Letter to the editor
Letter to the Editor Re: Wilson
et al. Outpatient
Extraperitoneal Single-Port
Robotic Radical
Prostatectomy. Urology
2020; 144: 142-146
We congratulate Kaouk et al1 for presenting their
encouraging data on outpatient robotic radical prostatectomy using the single port (SP) robot. Majority (»90%)
of patients had NCCN intermediate or high-risk prostate
cancer and underwent concomitant nerve-sparing
(90%), with about half harboring extraprostatic disease
and a quarter with positive margins on ﬁnal pathology.
About 90% of patients were able to be discharged the
same day, and opiates were increasingly less likely prescribed. These achievements reﬂect a truly commendable
work by the authors, especially in light of twin CoViD19 and opioid pandemics in the country. We have
recently adopted the SP robot as well, and would like to
seek some clariﬁcations in an attempt to optimize our
own patient outcomes.
 The authors’ prior publication2 seems to indicate that
the patients in the current study were part of the later
series of patients (ie, after the ﬁrst »40 cases with the
SP robot), given the timeline of reported cases. This
highlights the learning curve for these cases. It would
be interesting to see what technical/surgical changes
(other than from anesthesia/post-anesthesia care unit/
peri-op analgesia standpoint) were incorporated to
facilitate same-day discharge over this learning curve
period?
 What were the Indications, extent/template, and
median nodal yield for patients undergoing pelvic lymphadenectomy? Extraperitoneal robotic radical prostatectomy may be less conducive to an extensive lymph
node dissection,3 arguably even more so with the SP
approach.
 Did the authors encounter instances of the transperitoneal breach? If so, how were they handled and more
importantly, how did that affect the intraoperative
and perioperative pathway?
 Did the authors feel that factors such as obesity, prostate size/anatomy, or prior prostate surgeries were
important determinants in assessing the feasibility of
SP approach? On the basis of authors’ current and
prior reports, the median body mass index and prostate
size were »30 kg/m2 and 55-60 gm, respectively.
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 Could the authors elaborate on the reasons for readmission in 7% of the cohort? It seems that the most
important major complication (Clavien 3 or above)
rate was lymphocele requiring percutaneous drainage
(10%). Was it related to the extraperitoneal nature of
the operation or the extent of lymphadenectomy
(amongst other reasons)? The authors indicate that
they were able to reduce their lymphocele rate in the
later part of their series by using titanium clips; however, a previous randomized trial4 has shown that clips
may not decrease the rate of symptomatic lymphocele
compared to bipolar coagulation. Were there other
speciﬁc technical modiﬁcations that decreased the rate
of lymphocele, such as peritoneal interposition ﬂaps/
reconﬁguration,5 ﬁbrin glue,6 or more likely learning
curve-related factors (more meticulous dissection, better patient selection)?
 The authors report urinary continence (0-1 pad/day)
rate of »50% at 1 month. Do the authors feel that the
extraperitoneal SP approach affects continence recovery any differently than the conventional transperitoneal or a Retzius-sparing approach, and if so, what
would be the biologic rationale behind it?
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